Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study.
Michael LiuBrian MackennaWilliam B FeldmanAlex J WalkerJerry AvornAaron S KesselheimBen GoldacrePublished in: Journal of the Royal Society of Medicine (2020)
Spending by NHS England would be substantially higher if it paid US Medicare Part D prices. This could result in decreased access to medicines and other health services.